Paul Yu
Director, Cardiovascular Research Center (CVRC) at Massachusetts General Hospital · Stanford Health Care
Credentials: · · ·
History
- Present
Cardiovascular Research Center (CVRC) at Massachusetts General Hospital · Stanford Health Care
- Present
- 1999–2000
1995–1999
Research
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Nature Chemical Biology · 2008 · First of 9 authors · 876 citations
BMP type I receptor inhibition reduces heterotopic [corrected] ossification
Nature Medicine · 2008 · First of 15 authors · 536 citations
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
Nature Medicine · 2015 · 419 citations
- KB
16 papers
9 papers
- CL
8 papers · 3 as a resident
7 papers
- DB
7 papers
- DM
7 papers · 2 as a resident
6 papers
6 papers
Grants
- 1993–2028
Integrated, Multidisciplinary Training in Cardiovascular Research
National Heart, Lung, and Blood Institute · T32
PI · $2.9M · Massachusetts General Hospital
- 2021–2026
Context-Specific Angiogenic Signaling in the Pulmonary Vasculature
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.4M · Massachusetts General Hospital
- 2010–2025
Molecular and Cellular Mechanisms of Heterotopic Ossification
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $4.5M · Massachusetts General Hospital
- 2017–2021
HLS- Cyclic CAR Peptide: A Targeted Therapy for Pulmonary Hypertension
National Heart, Lung, and Blood Institute · R42
Contact PI · $2.3M · Vascular Biosciences
Clinical trials
- 2018–2020
Angiogenic Imaging in Pulmonary Arterial Hypertension
Principal investigator · Completed · Phase 1, Phase 2
Brigham and Women's Hospital